3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
2
Prostatic Neoplasms, Castration-Resistant
1
Neoplasm Metastasis
1
Metastatic Castration-resistant Prostate Cancer (mCRPC)
1
Interventions
pembrolizumab
2
radium Ra 223 dichloride
1
enzalutamide
1
efineptakin alfa
1
abiraterone
1
Radium-223
1
Pluvicto
1
PSMA-11
1
Lutetium-177
1
Lutetium
1
Injections
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Metastatic Castration-resistant Prostate Cancer (mCRPC)
×
Radium-223
×
Clear all
NCT03896984
2021-12-29
PHENIX
Bayer
Completed
346 enrolled